<?xml version="1.0" encoding="UTF-8"?>
<p>RHuIFN-α has been shown to be active against FIV 
 <italic>in vitro</italic> [
 <xref rid="B105-vetsci-02-00456" ref-type="bibr">105</xref>]. Although frequently used in the field for treating FIV-infected cats, controlled studies evaluating the effect of parenteral administration of rHuIFN-α in FIV-infected cats have not been conducted. 
</p>
